Novartis doubles investment in AveXis North Carolina site
In addition to the $55m previously invested, Novartis will spend a further $60m in expanding AveXis’ site in North Carolina enabling the manufacture of multiple gene therapies simultaneously.
Top Headlines
Global Industry News
-
Two more EU countries added to US mutual recognition project
from in-PharmaTechnologist.com
-
FDA’s draft guidance clears path for generic competition
from in-PharmaTechnologist.com
-
AI threatens health data privacy: Report
from Outsourcing-Pharma.com
-
‘The magic balance’: Diverse advisory boards guide clinical trial design
from Outsourcing-Pharma.com
